Highly polymorphic promoter regions of HLA DQA1 and DQB1 genes do not help to further define disease susceptibility in insulin-dependent diabetes mellitus

Tissue Antigens

Volumn 50, Issue 6, 1997, Pages 642-645

  Donner, H ^a   Bau, H ^a   Braun, J ^a   Herwig, J ^a   Usadel, K H ^a   Badenhoop, K ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Gene regulation; HLA DQA1; HLA DQB1; HLA DRB1; IDDM; Promoter polymorphism; SSCP

Indexed keywords

HLA DQ ANTIGEN;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION;

EID: 15144355030     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02923.x     Document Type: Article

References (18)

1. Atkinson MA, MacLaren NK. The pathogenesis of insulin-depending diabetes mellitus. N Engl J Med 1994: 331: 1428-1435.
2. Todd JA, Bell JI, McDevitt HO. HLA-DQb gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987: 329: 599-604.
3. She J. Susceptibility to type 1 diabetes: HLA-DQ and DR revisited. Immunol Today 1996: 17: 323-329.
4. Morzycka-Wroblewska E, Harwood JI, Smith JR, Kagnoff MF. Structure and evolution of the promoter regions of the DQA genes. Immunogenetics 1993: 37: 364-372.
5. Leech N, Sorrentino R, McCulloch DK, Nepom GT. Ultrastructural allelic variation in HLA-DQB1 promoter elements. Hum Immunol 1995: 43: 251-258.
6. Haas JP, Kimura A, Andreas A et al. Polymorphism in the upstream regulatory region of DQA1 genes and DRB1, QAP, DQA1 and DQB1 haplotypes in the German population. Hum Immunol 1994: 39: 31-40.
7. Reichstetter S, Krellner PH, Meenzen CM, Kalden JR, Wassmuth R. Comparative analysis of sequence variability in the upstream regulatory region of the HLA-DQB1 gene. Immunogenetics 1994: 39: 207-212.
8. Badenhoop K, Walfish PG, Rau H et al. Susceptibility and resistance alleles of human leukocyte antigene (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 1995: 80: 2112-2117.
9. Beaty JS, West KA, Nepom GT. Functional effects of a natural polymorphism in the transcriptional regulatory sequence of HLA-DQB1. Mol Cell Biol 1995: 15: 4771-4782.
10. Nepom GT, Chung J, West KA. Differential expression of HLA-DQB1 alleles in a heterozygous cell line. Immunogenetics 1995: 42: 143-148.
11. Marsh SGE. HLA class II nucleotide sequences, 1991. Immunogenetics 1991: 33: 321-334.
12. Picard JK. Single-step allele-specific polymerase chain reaction HLA-DQ genotyping using ARMS primers. Hum Immunol 1993: 38: 115-122.
13. Zetterquist H, Ollerup O. Identification of the HLA-DRB1*04, -DRB1*07 and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol 1992: 34: 64-74.
14. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1995. Tissue Antigens 1995: 46: 1-18.
15. Knight SW, Mijovic C, Barnett AH. HLA-DQB1 upstream regulatory region polymorphism and type 1 diabetes. Tissue Antigens 1996: 47: 231-236.
16. Khalil I, Deschamps I, Lepage V, Daccak R, Degos L, Hors J. Dose effect of cis- and trans-encoded HLA-DQαβ heterodimers in IDDM susceptibility. Diabetes 1992: 41: 378-384.
17. Cucca F, Todd JA. HLA susceptibility to type 1 diabetes: methods and mechanisms. In: Browning M, McMichael A, ed. HLA and MHC genes, molecules and function. Oxford: BIOS Scientific Publishers Limited, 1996: 383-406.
18. Badenhoop K, Tönjes RR, Rau H et al. Endogenous retroviral long terminal repeats of the HLA DQ region are associated with susceptibility to IDDM. Hum Immunol 1996: 50: 103-110.